| |
HIV-negative control group |
HIV-positive group |
| |
Aortic calcification score (%) |
|
| |
Total n=77 |
Total n=77 |
≤ 0.031 n=38 |
>0.031 n=39 |
p |
| Age (years) |
61.1 ± 6.9 |
47.1 ± 12.1 |
41.1 ± 9.9 |
53.0 ± 11.3 |
<0.0001 |
| Male gender, n (%) |
44 (57) |
52 (67.5) |
20 (52.6) |
32 (82.1) |
0.006 |
| BMI (kg/m2) |
27.0 ± 5.9 |
22.8 ± 4.7 |
23.4 ± 4.8 |
22.2 ± 4.7 |
0.307 |
| Smoking habit, n (%) |
14 (18.2) |
34 (44.1) |
13 (34.2) |
21 (56.4) |
0.053 |
| History of CV disease, n (%) |
12 (15.5) |
15 (19.5) |
4 (10.5) |
11 (28.2) |
0.046 |
| Lipodystrophy, n (%) |
- |
16 (20.8) |
7 (18.4) |
9 (23.0) |
0.413 |
| Diabetes, n (%) |
3 (4) |
3 (3.9) |
2 (5.2) |
1 (2.6) |
0.500 |
| Hypertension, n (%) |
31 (41) |
16 (20.8) |
4 (10.5) |
12 (30.8) |
0.027 |
| Systolic blood pressure (mmHg) |
129.0 ± 18 |
125.0 ± 16.4 |
123.9 ± 18.7 |
125.9 ± 14.5 |
0.695 |
| Diastolic blood pressure (mmHg) |
81 ± 12 |
73.9 ± 10.3 |
71.4 ± 9.6 |
76.0 ± 10.6 |
0.131 |
| Dyslipidemia, n (%) |
26 (33.7) |
26 (33.8) |
8 (30.8) |
18 (69.2) |
0.018 |
| Time since HIV diagnosis (years) |
- |
9.9 ± 7.6 |
7.6 ± 6.7 |
12.0 ± 7.9 |
0.011 |
| Stage A1, n (%) |
- |
2 (2.6) |
2 (5.2) |
0 (0.0) |
0.240 |
| Stage A2, n (%) |
- |
14 (18.2) |
8 (21.1) |
6 (15.4) |
0.364 |
| Stage A3, n (%) |
- |
24 (31.2) |
12 (31.6) |
12 (30.8) |
0.567 |
| Stage B1, n (%) |
- |
1 (1.3) |
0 (0.0) |
1 (2.6) |
0.506 |
| Stage B2, n (%) |
- |
3 (3.9) |
2 (5.3) |
1 (2.6) |
0.490 |
| Stage B3, n (%) |
- |
6 (7.8) |
3 (7.9) |
3 (7.7) |
0.650 |
| Stage C1, n (%) |
- |
1 (1.3) |
0 (0.0) |
1 (2.6) |
0.506 |
| Stage C2, n (%) |
- |
6 (7.8) |
5 (13.2) |
1 (2.6) |
0.094 |
| Stage C3, n (%) |
- |
20 (26.0) |
6 (15.8) |
14 (35.9) |
0.039 |
Data are expressed as mean ± SDor (for binary variables) the number (frequency).p: comparison within the HIV-positive group, as a function of the calcification score.
Abbreviations: BMI: body mass index; CV: cardioVascular.
Variables in bold type were found to be statistically significant. |
